Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
CP-312
Cat. No.:
OB0225LY-0463
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
CP-312 is a selective inhibitor that primarily targets specific enzymes and signaling channels with potential anti-tumor and anti-inflammatory properties.
Synonym:
CP312; Cardioprotectant 312; 895470-67-4; Cardioprotectant; 2-((4-Chlorophenyl)thio)-N-(4-(pyridin-2-yl)thiazol-2-yl)acetamide; 2-[(4-Chlorophenyl)sulfanyl]-N-[4-(pyridin-2-yl)-1,3-thiazol-2-yl]acetamide
CAS No.:
895470-67-4
Compound CID:
22581391
Formula:
C16H12ClN3OS2
Formula Weight:
361.87
Specification
Relative Density:
1.45 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
CP-312 can be used to study carcinogenesis and signaling pathways or to evaluate its biological activity during drug screening.
Library Information
Targets:
Antioxidant/Cytoprotective enzymes; Reactive species modulators
Receptors:
Reactive oxygen species; (HO)-1
Pathways:
Autophagy; Metabolism; Immunology/Inflammation; NF-κB
Plate Number:
AOCL-6
Plate Location:
h10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
45 mg/mL; 124.35 mM
